Issue link: https://beckershealthcare.uberflip.com/i/1472295
35 DEVICES & IMPLANTS US hospital 1st to perform pediatric spine surgery with NuVasive device By Alan Condon U niversity Hospitals Rainbow Babies & Children's Hos- pital in Cleveland became the first hospital to perform pediatric spine surgery with NuVasive's Pulse platform, NBC affiliate WKYC affiliate reported June 2. The device was used to perform a posterior spinal fusion on a 12-year-old girl with adolescent idiopathic scoliosis, the most common form of scoliosis, which affects 2 percent to 4 percent of adolescents. Pulse is an integrated platform designed to improve safety and efficiency in spine surgery, according to NuVasive. The technol- ogy touts a seamless workflow, allowing surgeons to use mul- tiple technologies in a single procedure, and can help "deliver improved operational, financial and clinical outcomes," CEO Chris Barry said during an earnings call in February. "Navigational platforms like Pulse are truly the future of sur- gery," Michael Glotzbecker, MD, chief of the pediatric orthope- dic surgery division at UH Rainbow Babies & Children's, told WKYC. "We chose Pulse because of its impressive intraopera- tive imaging and navigation, combined with radiation reduc- ing techniques that help us provide the best outcomes for the children and young adults we care for each day." n NuVasive sued by analytics company; contract breach alleged By Carly Behm T rilliant Health is suing NuVasive for $1 million over allegations that the spine devicemaker breached a five- year agreement. Six things to know: 1. NuVasive was interested in Trilliant's surgical data analytics platform to find sur- geons who may be interested in buying their spine products, according to a lawsuit filed June 6 in the Middle District of Tennessee court. On June 24, 2021, Trilliant and Nu- Vasive signed a five-year agreement giving NuVasive access to Trilliant's surgical data analytics platform and a one-year exclusivity provision preventing Trilliant from offering certain NuVasive competitors access to the platform. 2. NuVasive agreed to pay $253,300 annually for five years as part of the agreement. 3. In December 2021, NuVasive asked if Trilliant could mutually agree to terminate the contract over concerns about the volume of Trilliant's data. Trilliant refused. 4. On Feb. 7, NuVasive allegedly sent a no- tice of termination letter claiming Trilliant breached the contract. Trilliant responded in a letter 10 days later denying any breach and asked for pre-lawsuit mediation that was unsuccessful. 5. Trilliant's lawsuit argues that NuVasive has no legal right to terminate the agreement since Trilliant didn't breach their contract. 6. Trilliant is asking for $1 million in damages. Note: NuVasive declined to comment. n Stryker to sell orthopedic surgical system By Alan Condon O nkos Surgical, a devicemaker specializing in musculoskeletal oncology and complex ortho- pedics, on June 13 entered into a definitive agreement to acquire Stryker's Juvenile tumor system. The Juvenile tumor system enables limb stabilization and growth in pediatric patients affected by bone can- cers, severe arthropathy, trauma, revisions, oncology and malignant diseases. The device allows for noninvasive lengthening of the implant post-surgery over time, according to Stryk- er. Its design eliminates the need for multiple limb- lengthening surgeries, anesthesia or sedation, which helps reduce the risk of complications and the cost of limb reconstruction. "Our 'why' has always driven us to specifically address the many clinical challenges the [musculoskeletal oncol- ogy] community of surgeons and patients face on a daily basis," Patrick Treacy, co-founder and CEO of Onkos Sur- gical, said in a company news release. "Pediatric cancer surgery and limb lengthening are complex and chal- lenging procedures, and the JTS extendible prosthesis is a solution in service of this mission." n